Skip to main content
. 2020 Feb 28;1:28–41. doi: 10.1016/j.jvssci.2020.02.001

Table.

Patients' characteristics

Characteristic Healthy (n = 6) mPAD (n = 6) sPAD (n =5)
Age, years 56.8 (54-62) 73.8 (72-76) 69 (68-82)
Male sex 2 (33.3) 4 (66.7) 4 (80)
Clinical measurements at baseline
 Creatinine concentration, mg/dL 0.84 (0.16) 1.14 (0.16) 1.00 (.30)
 ABI 0.71 (0.45-0.80) 0.74 (0.57-0.79)
 Rutherford stage 2.5 (2-3) 4 (3-5)
Medical history
 Coronary artery disease 0 1 (16.7) 1 (20)
 Hypertension 0 6 (100.0) 5 (100)
 Hyperlipidemia 0 6 (100.0) 5 (100)
 Diabetes 0 2 (33.3) 4 (80)
Tobacco use
 Never 4 (66.7) 0 (0.0) 1 (20)
 Current 0 1 (16.7) 1 (20)
  Pack years smoked 30 50
 Former 2 (33.3) 5 (83.3) 3 (60)
  Pack-years smoked 4 (3.88-12) 35 (24-40) 60 (35-60)
Takes daily aspirin 0 6 (100.0) 4 (80)
Takes daily statin 0 5 (83.3) 3 (60)

ABI, Ankle-brachial index; mPAD, mild peripheral artery disease; sPAD, severe peripheral artery disease.

Categorical variables are presented as number (%). Continuous variables are presented as mean (standard deviation) or median (interquartile range).

Mild PAD is defined as ABI <0.9 with intermittent, nondisabling claudication, Rutherford stage 2 to 3. Severe PAD is defined as ABI <0.9 warranting lower extremity bypass grafting, Rutherford stage 3 to 5.